Abstracts featured at the National Kidney Foundation Spring Clinical Meeting highlighted the renoprotective benefits of SGLT2 inhibitors in heart failure and diabetic kidney disease while emphasizing ...

Progression-free survival improvement and drug costs make zanubrutinib a more cost-effective option in relapsed or refractory chronic lymphocytic leukemia (CLL), new research suggests.

Patients with chronic spontaneous urticaria experienced a long delay in diagnosis, a substantial impact on their quality of life, and often received inadequate treatment, highlighting the need for ...

Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.

Cathy Eng, MD, FACP, FASCO, participated on the panel discussion, “Health Equity in Cancer Care Delivery,” during the January ...

Interventions that target enhancing health care equity among communities disproportionately affected by the COVID-19 pandemic ...

Findings from a new study reveal how hurricanes and the pandemic disrupted colorectal cancer (CRC) screenings in Puerto Rico, ...

An expert discusses how the VISIBLE study examined comorbidity burden in moderate to severe psoriasis across all skin tones, addressing disparities in research. It aimed to highlight unmet needs and ...

Sam Peasah, PhD, MBA, RPh, director of High-Value Health Care Value-Based Pharmacy Initiatives at UPMC Health Plan, discusses common barriers to adherence, including forgetfulness, cost, side effects, ...

While artificial intelligence (AI) use in health care is currently limited to administrative tasks, Erin Weber, MS, explains that expanding its adoption will require greater collaboration, ...

Experts discuss how guideline recommendations influence formulary decisions regarding preventive measures like lipoprotein(a) ...

Beau Raymond, MD, elaborates on what successful patient-centered care entails, highlighting the role of patients to not only judge the success of their own care but also help guide clinicians as they ...